Drawing for DISALCID

USPTO serial 97370152

DISALCID

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SPARACINO, MARK V
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DISALCID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephen A. Seach, Jr.

Stephen A. Seach, Jr. SERVILLA WHITNEY LLC33 WOOD AVENUE SOUTHSUITE 830ISELIN, NJ 08830

Goods and services

ClassDescriptionStatusFirst use
005anti-inflammatory analgesic pharmaceutical preparationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 5, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 5, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 24, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 24, 2026EX5GSOU EXTENSION 5 GRANTED—
Jun 24, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 12, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 11, 2026EXT5SOU EXTENSION 5 FILED—
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 4, 2025EX4GSOU EXTENSION 4 GRANTED—
Sep 4, 2025EXT4SOU EXTENSION 4 FILED—
Sep 4, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 17, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 16, 2025EX3GSOU EXTENSION 3 GRANTED—
Feb 16, 2025EXT3SOU EXTENSION 3 FILED—
Feb 16, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 15, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 15, 2024EX2GSOU EXTENSION 2 GRANTED—
Aug 15, 2024EXT2SOU EXTENSION 2 FILED—
Aug 15, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 15, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 15, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 15, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 15, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 15, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 6, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 5, 2024EX1GSOU EXTENSION 1 GRANTED—
Mar 5, 2024EXT1SOU EXTENSION 1 FILED—
Mar 5, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 5, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 23, 2023ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Apr 12, 2023ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 14, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 14, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 22, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 8, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 8, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Feb 8, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 8, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 8, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 6, 2023DOCKASSIGNED TO EXAMINER—
Apr 26, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 22, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance